Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis

References

• Gurney M. E., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 1994; 264: 1772–5
   PubMed Web of Science ®Google Scholar
• Boillee S., Yamanaka K., Lobsiger C. S., Copeland N. G., Jenkins N. A., Kassiotis G., et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006; 312: 1389–92
   PubMed Web of Science ®Google Scholar
• Mohajeri M. H., Figlewicz D. A., Bohn M. C. Selective loss of motor neurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 1998; 50: 329–36
   Google Scholar
• Ligon L. A., LaMonte B. H., Wallace K. E., Weber N., Kalb R. G., Holzbaur E. L. F. Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons. Neuroreport 2005; 6: 533–6
   Google Scholar
• Atkin J. D., Scott R. L., West J. M., Lopes E., Quah A. K. J., Cheema S. S. Properties of slow‐ and fast‐twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromusc Dis 2005; 15: 377–88
   PubMedGoogle Scholar
• Kong J., Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing mutant SOD1. J Neurosci 1998; 18: 3241–50
   PubMed Web of Science ®Google Scholar
• Fischer L. R., Culver D. G., Tennant P., Davis A. A., Wang M., Castellano‐Sanchez A., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004; 185: 232–40
   PubMed Web of Science ®Google Scholar
• Derave W., van den Bosch L., Lemmens G., Eijnde B. O., Robberecht W., Hespel P. Skeletal muscle properties in a transgenic mouse model for amytrophic lateral sclerosis: effects of creatine treatment. Neurobiol Dis 2003; 13: 264–72
   PubMed Web of Science ®Google Scholar
• Leger B., Vergani L., Soraru G., Hespel P., Gobelet C., D'Ascenzio C., et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin‐1. FASEB J 2006; 20: 583–5
   PubMed Web of Science ®Google Scholar
• Rommel C., Bodine S. C., Clarke B. A., Rossman R., Nunez L., Stitt T. N., et al. Mediation of IGF‐1‐induced skeletal myotube hypertrophy by PI(3)K/PKB/mTOR and PI(3)K/PKB/GSK3 pathways. Nat Cell Biol 2004; 3: 1009–13
   Google Scholar
• Li M., Li C., Parkhouse W. S. Age‐related differences in the des IGF‐I‐mediated activation of PKB‐1 and p70 S6K in mouse skeletal muscle. Mech Ageing Dev 2003; 124: 771–8
   PubMed Web of Science ®Google Scholar
• Dudek S. M., Fields R. D. Mitogen‐activated protein kinase/extracellular signal‐regulated kinase activation in somatodendritic compartments: roles of action potentials, frequency, and mode of calcium entry. J Neurosci 2001; 21: 1–5
   Google Scholar
• Hu J. H., Chernoff K., Pelech S., Krieger C. Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD overexpressing mice. J Neurochem 2003; 85: 422–31
   PubMed Web of Science ®Google Scholar
• Zhang H., Shi X., Zhang Q. J., Hampong M., Paddon H., Wahyuningsih D., et al. Nocodazole‐induced p53‐dependent c‐Jun N‐terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells. J Biol Chem 2002; 277: 43648–58
   PubMedGoogle Scholar
• Covault J., Sanes J. R. Distribution of N‐CAM in synaptic and extrasynaptic portions of developing and adult skeletal muscle. J Cell Biol 1986; 102: 716–30
   PubMed Web of Science ®Google Scholar
• Feeney S. J., McKelvie P. A., Austin L., Jean‐Francois M. J., Kapsa R., Tombs S. M., et al. Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2001; 24: 1510–9
   PubMed Web of Science ®Google Scholar
• Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motor neuron diseases. J Neurosci 2000; 20: 2534–42
   PubMed Web of Science ®Google Scholar
• Kieran D., Hafezparast M., Bohnert S., Dick J. R. T., Martin J., Schiavo G., et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 2005; 169: 561–7
   PubMed Web of Science ®Google Scholar
• Li S., Wang X., Klee C. B., Krieger C. Overexpressed mutant G93A superoxide dismutase protects calcineurin from inactivation. Mol Brain Res 2004; 125: 156–61
   PubMedGoogle Scholar
• Jaarsma D., Haasdijk E. D., Grashorn J. A. C., Hawkins R., van Duijn W., Verspaget H. W., et al. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration and premature motor neuron death and accelerates motor neuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis 2000; 7: 623–43
   PubMed Web of Science ®Google Scholar
• Sanes J. R., Schachner M., Covault J. Expression of several adhesive macromolecules (N‐CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin, and heparin sulphate proteoglycan) in embryonic, adult, and denervated adult skeletal muscle. J Cell Biol 1986; 102: 420–31
   PubMed Web of Science ®Google Scholar
• Cashman N. R., Covault J., Wollman R. L., Sanes J. R. Neural cell adhesion molecule in normal, denervated, and myopathic human muscle. Ann Neurol 1987; 21: 481–9
   PubMed Web of Science ®Google Scholar
• Tews D. S., Goebel H. H., Schneider I., Gunkel A., Stennert E., Neiss W. F. Expression profile of stress proteins, intermediate filaments, and adhesion molecules in experimentally denervated and re‐innervated rat facial muscle. Exp Neurol 1997; 146: 125–34
   PubMed Web of Science ®Google Scholar
• Schoser B. G., Wehling S., Blottner D. Cell death and apoptosis‐related proteins in muscle biopsies of sporadic amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve 2001; 24: 1083–9
   PubMedGoogle Scholar
• Bodine S. C., Stitt T. N., Gonzalez M., Kline W. O., Stover G. L., Bauerlein R., et al. PKB/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001; 3: 1014–9
   PubMed Web of Science ®Google Scholar
• Rommel C., Bodine S. C., Clarke B. A., Rossman R., Nunez L., Stitt T. N., et al. Mediation of IGF‐1‐induced skeletal myotube hypertrophy by PI(3)K/PKB/mTOR and PI(3)K/PKB/GSK3 pathways. Nat Cell Biol 2001; 3: 1009–13
   PubMed Web of Science ®Google Scholar
• Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., et al. Muscle expression of local Igf‐1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 2005; 168: 193–9
   PubMed Web of Science ®Google Scholar
• Kaspar B. K., Llado J., Sherkat N., Rothstein J. D., Gage F. H. Retrograde viral delivery of IGF‐1 prolongs survival in a mouse ALS model. Science 2003; 301: 839–42
   PubMed Web of Science ®Google Scholar
• Boillee S., Cleveland D. W. Gene therapy for ALS delivers. Trends Neurosci 2004; 27: 235–8
   PubMed Web of Science ®Google Scholar